Duration of equine influenza virus shedding and infectivity in immunised horses after experimental infection with EIV A/eq2/Richmond/1/07

Veterinary Microbiology

Volumn 166, Issue 1-2, 2013, Pages 22-34

  Paillot, R ^a   Prowse, L ^a   Montesso, F ^a   Stewart, B ^b   Jordon, L ^b   Newton, J R ^a   Gilkerson, J R ^c  

^a ANIMAL HEALTH TRUST   (United Kingdom)

^b Racing Analytical Services Limited   (Australia)

^c The University of Melbourne   (Australia)

Author keywords

Equine influenza; Nasal shedding, Nasopharyngeal shedding; Protection; Vaccine

Indexed keywords

NUCLEOPROTEIN;

ARTICLE; BRONCHIAL ASPIRATION PROCEDURE; CLADISTICS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; EGG; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUINE INFLUENZA; EXPERIMENTAL INFECTION; HEN; HORSE; IMMUNIZATION; INFECTION CONTROL; INFECTION SENSITIVITY; INFLUENZA VACCINATION; INFLUENZA VIRUS; INTERMETHOD COMPARISON; MOVEMENT (PHYSIOLOGY); NASOPHARYNX; NONHUMAN; NOSE SMEAR; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UNITED STATES; VIRUS DETECTION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS SHEDDING; VIRUS TITRATION; VIRUS TRANSMISSION;

EQUINE INFLUENZA; NASAL SHEDDING, NASOPHARYNGEAL SHEDDING; PROTECTION; VACCINE;

ANIMALS; ANTIBODIES, VIRAL; AUSTRALIA; DISEASE OUTBREAKS; HORSE DISEASES; HORSES; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE INFECTIONS; VACCINATION; VIRUS SHEDDING;

ANIMALIA; EQUIDAE; EQUINE INFLUENZA VIRUS;

EID: 84880512471     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.04.027     Document Type: Article

References (33)

1. Bryant N.A., Paillot R., Rash A.S., Medcalf E., Montesso F., Ross J., Watson J., Jeggo M., Lewis N.S., Newton J.R., Elton D.M. Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak. Vet. Res. 2010, 41:19.
2. Bryant N.A., Rash A.S., Russell C.A., Ross J., Cooke A., Bowman S., Macrae S., Lewis N.S., Paillot R., Zanoni R., Meier H., Griffiths L.A., Daly J.M., Tiwari A., Chambers T.M., Newton J.R., Elton D.M. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet. Microbiol. 2009, 138:41-52.
3. Daly J.M., Sindle T., Tearle J., Barquero N., Newton J.R., Corning S. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study. Equine Vet. J. 2007, 39:446-450.
4. Daly J.M., Yates P.J., Newton J.R., Park A., Henley W., Wood J.L., Davis-Poynter N., Mumford J.A. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines. Vaccine 2004, 22:4101-4109.
5. Daly J.M., Yates R.J., Browse G., Swann Z., Newton J.R., Jessett D., Davis-Poynter N., Mumford J.A. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines. Equine Vet. J. 2003, 35:458-462.
6. Edlund Toulemonde C., Daly J., Sindle T., Guigal P.M., Audonnet J.C., Minke J.M. Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Vet. Rec. 2005, 156:367-371.
7. Gildea S., Arkins S., Walsh C., Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt Horses - a randomised blind study. Vaccine 2011, 29:3917-3922.
8. Gildea S., Arkins S., Walsh C., Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings - a randomised blind study. Vaccine 2011, 29:9214-9223.
9. Guthrie A.J., Stevens K.B., Bosman P.P. The circumstances surrounding the outbreak and spread of equine influenza in South Africa. Rev. Sci. Tech. 1999, 18:179-185.
10. Hannant D., Jessett D.M., O'Neill T., Livesay G.J., Mumford J.A. Cellular immune responses stimulated by inactivated virus vaccines and infection with equine influenza virus (H3N8). Equine Infectious Diseases VII: Proceedings of Seventh International Conference on Equine Infectious Diseases 1994, 169-174. R & W Publications Ltd, Newmarket, UK. H. Nakajima, W. Plowright (Eds.).
11. Heldens J.G., Pouwels H.G., Derks C.G., Van de Zande S.M., Hoeijmakers M.J. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap. Vaccine 2009, 27:5530-5537.
12. Heldens J.G.M., Pouwels H.G.W., Van Loon A.A.W.M. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95). Vet. J. 2004, 167:150-157.
13. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
14. Landolt G., Townsend H.G., Lunn D.P. Equine influenza infection. Equine Infectious Diseases 2007, 124-134. Saunders Elseiver. D.C. Sellon, M.T. Long (Eds.).
15. Minke J.M., Toulemonde C.E., Coupier H., Guigal P.M., Dinic S., Sindle T., Jessett D., Black L., Bublot M., Pardo M.C., Audonnet J.C. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge. Am. J. Vet. Res. 2007, 68:213-219.
16. Moloney B.J. Overview of the epidemiology of equine influenza in the Australian outbreak. Aust. Vet. J. 2011, 89(Suppl 1):50-56.
17. Mumford J.A. Control of influenza from an international perspective. Equine Infectious Diseases VIII: Proceedings of the 8th International Conference on Equine Infectious Diseases 1998, 11-24. R&W Publications (Newmarket), Newmarket, UK. U. Wernery, J.F. W, J.A. Mumford, O.-R. Kaaden (Eds.).
18. Mumford J.A., Jessett D.M., Dunleavy U., Wood J.L.N., Hannant D., Sundquist B., Cook R.F. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine 1994, 12:857-863.
19. Mumford J.A., Wood J. Establishing an acceptability threshold for equine influenza vaccines. Dev. Biol. Stand. 1992, 79:137-146.
20. OIE Equine influenza: chapter 2.5.7. OIE Terrestrial Manual 2012 2012.
21. OIE OIE expert surveillance panel on equine influenza vaccine composition. OIE Bull. 2012, 2:46-47.
22. Paillot R., Grimmett H., Elton D., Daly J.M. Protection, systemic IFN and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host. Vet. Res. 2008, 39:21.
23. Paillot R., Hannant D., Kydd J.H., Daly J.M. Vaccination against equine influenza: quid novi?. Vaccine 2006, 24:4047-4061.
24. Paillot R., Kydd J.H., Sindle T., Hannant D., Edlund Toulemonde C., Audonnet J.C., Minke J.M., Daly J.M. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus. Vet. Immunol. Immunopathol. 2006, 112:225-233.
25. Paillot R., Prowse L., Donald C., Medcalf E., Montesso F., Bryant N., Watson J., Jeggo M., Elton D., Newton R., Trail P., Barnes H. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding. Vet. Immunol. Immunopathol. 2010, 136:272-283.
26. Paillot R., Prowse L., Montesso F., Huang C.M., Barnes H., Escala J. Whole inactivated equine influenza vaccine: efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity. Vet. Microbiol. 2013, 162:396-407.
27. Quinlivan M., Cullinane A., Nelly M., Van Maanen K., Heldens J., Arkins S. Comparison of sensitivities of virus isolation, antigen detection, and nucleic acid amplification for detection of equine influenza virus. J. Clin. Microbiol. 2004, 42:759-763.
28. Quinlivan M., Dempsey E., Ryan F., Arkins S., Cullinane A. Real-time reverse transcription PCR for detection and quantitative analysis of equine influenza virus. J. Clin. Microbiol. 2005, 43:5055-5057.
29. Ragni-Alunni R., Van de Zande S. Efficacy of Equilis Prequenza Te against recent equine influenza isolates. Animal studies with individual challenge method. Equitana 2009 2009.
30. Reed L.J., Muench H. A simple method of estimating fifty percente endpoints. Am. J. Hygiene 1938, 27:493-497.
31. Van de Zande S., Ragni-Alunni R. Efficacy of Equilis Prequenza in horses individually challenged with A/equi2/Newmarket/5/03. 10th International Congress of World Equine Veterinary Association 2008, 428-430.
32. Watson P.F., Petrie A. Method agreement analysis: a review of correct methodology. Theriogenology 2010, 73:1167-1179.
33. Yamanaka T., Niwa H., Tsujimura K., Kondo T., Matsumura T. Epidemic of equine influenza among vaccinated racehorses in Japan in 2007. J. Vet. Med. Sci. 2008, 70:623-625.